Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma

Andrew Quon; Nancy J Fischbein; I Ross McDougall; Quynh-Thu Le; Billy W Loo Jr; Harlan Pinto; Michael J Kaplan

Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma

J Nucl Med. 2007 Jan:48 Suppl 1:58S-67S.

Authors

Andrew Quon¹, Nancy J Fischbein, I Ross McDougall, Quynh-Thu Le, Billy W Loo Jr, Harlan Pinto, Michael J Kaplan

Affiliation

¹ Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California 94305, USA. aquon@stanford.edu

PMID: 17204721

Abstract

18F-FDG PET/CT has rapidly become a widely used imaging modality for evaluating a variety of malignancies, including squamous cell carcinoma of the head and neck and thyroid cancer. Using both published data and the multidisciplinary experience at our institution, we provide a practical set of guidelines and algorithms for the use of 18F-FDG PET/CT in the evaluation and management of head and neck cancer and thyroid cancer.

Publication types

Review

MeSH terms

Carcinoma, Squamous Cell / diagnosis*
Carcinoma, Squamous Cell / therapy
Fluorodeoxyglucose F18*
Head and Neck Neoplasms / diagnosis*
Head and Neck Neoplasms / therapy
Humans
Positron-Emission Tomography / methods*
Positron-Emission Tomography / standards
Practice Guidelines as Topic
Practice Patterns, Physicians' / standards
Radiopharmaceuticals
Subtraction Technique
Systems Integration
Thyroid Neoplasms / diagnosis*
Thyroid Neoplasms / therapy
Tomography, X-Ray Computed / methods*
Tomography, X-Ray Computed / standards
United States
Whole Body Imaging / methods*
Whole Body Imaging / standards

Substances

Radiopharmaceuticals
Fluorodeoxyglucose F18